Fenfluramine

Valvular Heart Disease and Pulmonary Arterial Hypertension

  • There is an association between serotonergic drugs with 5-HT2B receptor agonist activity, including fenfluramine (the active ingredient in FINTEPLA), and valvular heart disease and pulmonary arterial hypertension. 
  • Echocardiogram assessments are required before, during, and after treatment with FINTEPLA. 
  • FINTEPLA is available only through a restricted program called the FINTEPLA REMS

Patient counseling

REMS

FINTEPLA (fenfluramine) Oral Solution)

Medical guidelines

Patient Medication Guide - GINTEPLA

Package inserts

Fenfluramine 

Keywords: Fintepla
Updated: July 2020